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Background: Vitamin C is an essential nutrient for maintain-
ing human life. Vitamin C insufficiency in the plasma is 
closely related with the development of scurvy. However, in 
vivo kinetics of vitamin C regarding its storage and con-
sumption is still largely unknown. Methods: We used 
Gulo
−/− mice, which cannot synthesize vitamin C like 
human. Vitamin C level in plasma and organs from Gulo
−/− 
mice was examined, and it compared with the level of 
wild-type mice during 5 weeks. Results: The significant 
weight loss of Gulo
−/− mice was shown at 3 weeks after vi-
tamin C withdrawal. However, there was no differences be-
tween wild-type and vitamin C-supplemented Gulo
−/− 
mice (3.3 g/L in drinking water). The concentration of vita-
min C in plasma and organs was significantly decreased at 1 
week after vitamin C withdrawal. Vitamin C is preferentially 
deposited in adrenal gland, lymph node, lung, and brain. 
There were no significant changes in the numbers and 
CD4/CD8 ratio of splenocytes in Gulo
−/− mice with vita-
min C withdrawal for 4 weeks. And the architecture of 
spleen in Gulo
−/− mice was disrupted at 5 weeks after vita-
min C withdrawal. Conclusion: The vitamin C level of 
Gulo
−/− mice was considerably decreased from 1 week af-
ter vitamin C withdrawal. Vitamin C is preferentially stored 
in some organs such as brain, adrenal gland and lung.
[Immune Network 2012;12(1):18-26]
INTRODUCTION
Vitamin C is a co-factor of some enzymes such as dopamine-
β-hydroxylase and collagen synthase which are essential for 
the life (1-3). That is to say, vitamin C insufficiency affects 
severe defects on cardiac function and skeletal systems due 
to the deficiency on the production of hormones and collagen 
(4,5). In addition, vitamin C plays an important role on the 
defense  system  against  viral  infection  and  the  development 
of cancer (6-8). Even though there are still the arguments re-
garding the anti-viral and anti-tumor activity of vitamin C in 
vivo, lots of experiment in vitro showed that vitamin C is one 
of the effective nutrients for the prevention of tumor develop-
m e n t  a n d  c a n c e r  t h e r a p y .
    It is known that vitamin C (L-ascorbic acid) is synthesized 
from  glucose,  during  the  glycolytic  pathway  and  L-gulono-
lactone-γ-oxidase (gulo) is one of the essential enzymes for 
the synthesis of vitamin C, especially conversion of L-gulono-
lactone to L-ascorbic acid (9,10). In the case of human being 
and some primates, a mutation of the gene encoded gulo is 
considered as the reason of the defect on the production of 
vitamin C (11). However, most of experimental animals could 
produce vitamin C by themselves, except guinea pig. Gulo
−/− 
mice  were  generated  and  used  for  the  investigation  of  the 
effect of vitamin C on the prevention of the formation of athe-
rosclerotic plaque upon vitamin C insufficiency (12). There-
fore,  the  limitation  of  in  vivo  experiments  about  the  effect In vivo Kinetics of Vitamin C in Gulo
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of vitamin C on the prevention or facilitation of development 
of  diseases  upon  vitamin  C  supplementation  or  withdrawal 
has  been  overcome.
    Regarding in vivo vitamin C pharmacokinetics, it was re-
ported that plasma vitamin C concentration reaches the peak 
concentration at 2∼3 hrs after administration (13). When vi-
tamin C is administered via intravenous injection, its concen-
tration in serum is 5∼6 times higher than that of oral admin-
istration, and it is drastically decreased at 6 hrs after admini-
stration. According to the report by Harrison et al. (14), vita-
min C is preferentially deposited in brain (4∼10 mM), adre-
nal gland (2∼10 mM), liver (0.8∼1 mM) and cerebrospinal 
fluids (CSF; 0.2∼0.4 mM). However, the reason why such 
organs  contain  the  high  concentration  of  vitamin  C  is  still 
largely unknown. Moreover, in vivo kinetics of vitamin C in 
organs  under  vitamin  C  insufficient  condition  has  not  been 
investigated yet. Therefore, we examined the changes of vita-
min C concentration in organs of Gulo





−/− m i c e  w e r e  o b t a i n e d  f r o m  t h e  M u t a n t  M o u s e  
Regional  Resource  Center  (University  of  California,  Davis, 
USA). C57BL/6 wild-type and the Gulo
−/− mice were main-
tained in a specific pathogen-free condition at an animal fa-
cility  in  the  Seoul  National  University  College  of  Medicine. 
Male  Gulo
−/−  mice  (4∼5  weeks  old)  were  maintained  for 
5  w e e k s  w i t h  o r  w i t h o u t  v i t a m i n  C  ( 3 . 3  g / L  o r  0 . 3 3  g / L ,  
Sodium  L-ascorbate,  Sigma,  St.  Louis,  MO,  USA)  supple-
mentation in drinking water. The animal use protocol for the 
experiment (approved No. SNU-080624-3 and SNU-100428-3) 
was reviewed and approved by the Ethics Committee of the 
Seoul  National  University.
Sample preparation
During the experimental periods for 5 weeks, plasma and or-
gans were collected from wild-type and Gulo
−/− mice with 
or without vitamin C supplementation at every week. Tissues 
were quickly frozen in liquid nitrogen, and then stored at 
−70
oC until use. After weighting, tissues were homogenized 
with TissueLyser II (Qiagen, Germany) in phosphate buffered 
saline (PBS). The homogenates were centrifuged with 14,000 
rpm at 4
oC for 30 min, and the supernatants were used for 
vitamin  C  measurement.
Measurement of vitamin C concentration
Plasma and tissue homogenates were diluted in PBS. Vitamin 
C  (ascorbic  acid,  AA)  converted  into  dehydroascorbic  acid 
(DHA), an oxidized form of ascorbic acid, and then the con-
centration of total DHA was measured by using a colorimetric 
microtiter plate assay kit (Immundiagnostik AG, Germany) ac-
cording to the manufacturer’s instructions. The final concen-
tration of vitamin C in each tissue was normalized to tissue 
weight.
Isolation of splenocytes and flow cytometry
S p l e e n  w a s  r e m o v e d  a n d  p l a c e d  i n t o  c o l d  w a s h i n g  m e d i a ,  
which  is  RPMI  media  containing  10%  heat-inactivated  fetal 
bovine serum, 100 U/ml penicillin, and 100μg/ml streptomy-
cin (GIBCO, Carlsbad, CA, USA). Spleen was homogenized 
by passing through 70μm nylon mesh (BD Bioscience, San 
Jose, CA, USA) and centrifuged at 600 g for 10 min. The pel-
let  was  re-suspended  in  red  blood  cell  lysis  buffer  (Sigma, 
St. Louis, MO, USA), and washed with washing media. The 
isolated splenocytes were stained with trypan blue (GIBCO, 
Carlsbad, CA, USA), and countered. Freshly isolated spleno-
cytes were resuspended in FACS buffer containing 0.5% BSA 
and  blocked  at  4
oC  for  10  min  with  Fc  blocking  reagent 
(Miltenyi Biotec GmbH, Germany). Then, cells were stained 
with anti-CD4 and anti-CD8 antibodies (BD Bioscience, San 
J o s e ,  C A ,  U S A )  o n  i c e  f o r  3 0  m i n  a n d  w a s h e d  t w i c e  w i t h  
FACS  buffer.  Cells  were  analyzed  by  FACS  Calibur  (BD 
Bioscience, San Jose, CA, USA). FlowJo software (Tree Star, 
Ashland,  OR,  USA)  was  used  for  the  data  analysis.
Histological examination
Spleens  were  freshly  excised,  and  fixed  in  4%  paraformal-
dehyde.  The  paraffin-embedded  sections  (5μm  thickness) 
were  deparaffinized  with  xylene  and  hydrated  by  alcohol 
series. Then, sections sere stained with hematoxylin and eo-
sin (H&E, Sigma, St. Louis, MO, USA) according to the manu-
facturer’s instructions. After mounting, stained sections were 
viewed  with  inverted  light  microscopy  (Olympus,  Center 
Valley,  PA,  USA).
Statistical analysis
Data  were  expressed  as  mean±S.D.  of  each  group  in  in-
dependent  experiments.  For  comparison  of  three  or  more 
groups, data were analyzed by one-way analysis of variance 
(ANOVA),  followed  by  Newman-Keuls  multiple  comparison 
test.  A  value  of  p＜0.05  was  considered  to  be  statistically In vivo Kinetics of Vitamin C in Gulo
−/− Mice
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Figure 1. Loss of weight and de-
crease of plasma vitamin C con-
centration in Gulo
−/− mice upon 
vitamin C withdrawal. (A) Pheno-
type of wild-type (WT) and Gulo
−/−
mice (KO) with vitamin C with-
drawal for 5 weeks. (B) Changes of 
body weight upon vitamin C with-
drawal were followed for 5 weeks 
(n=10). (C) The concentration of 
vitamin C of WT and Gulo
−/− mice 
in plasma (n=4∼10). ***p＜0.001 
vs. vitamin C- supplemented Gulo
−/−
mice (KO＋VC, 3.3 g/L).
significant. Statistical tests were carried out using GraphPad 
InStat  (GraphPad  Software,  San  Diego,  CA,  USA).
RESULTS
Loss of weight and decrease of plasma vitamin C con-
centration in Gulo
−/− mice upon vitamin C withdrawal
We first investigated the phenotypic changes of Gulo
−/− mice 
upon vitamin C withdrawal for 5 weeks. A skeletal change 
was  observed  from  Gulo
−/−  mice  without  supplementation 
of vitamin C for 5 weeks (Fig. 1A). We found the decreased 
movement of Gulo
−/− mice upon vitamin C withdrawal (data 
not  shown).  As  shown  in  Fig.  1B,  weight  loss  began  at  3 
weeks  after  vitamin  C  withdrawal  and  aggravated  with 
weeks. We next compared the plasma concentration of vita-
min C in four experimental groups; wild-type, Gulo
−/− mice 
w it h v it am in  C  su ppl em e nt at io n  (3 . 3 g / L o r 0 . 33  g / L),  an d 
Gulo
−/− mice without vitamin C supplementation. There was 
no difference between wild-type and Gulo
−/− mice supple-
mented with 3.3  g/L concentration of vitamin C. However, 
remarkable decrease of vitamin C concentration to sub-scurvy 
levels (less that 30μM) was observed at 1 week after vitamin 
C withdrawal and it lasted for 5 weeks (Fig. 1C). In addition, 
p l a s m a  l e v e l s  o f  v i t a m i n  C  i n  Gulo
−/−  mice  supplemented 
w i t h  0 . 3 3  g / L  o f  v i t a m i n  C  w a s  c o m p a r e d  w i t h  t h a t  o f  
wild-type and Gulo
−/− mice supplemented with 3.3 g/L of 
vitamin  C.  As  a  result,  it  levels  in  Gulo
−/− m i c e  s u p p l e -
mented with 0.33 g/L could not reach at the concentration 
in wild-type and Gulo
−/− mice supplemented with 3.3 g/L 
of vitamin C. It suggests that the optimal concentration of vi-
tamin C is 3.3 g/L for the examination of physiological effects 
of  vitamin  C  in  vivo.
The changes of vitamin C concentration in gastro-
intestinal organs
In  general,  vitamin  C  uptake  mainly  occurred  in  gastro-
intestinal tracts via the vitamin C-specific transporters, sodium 
dependent  vitamin  C  transporter  (SVCT)-1  and  -2  (15). 
Therefore, the concentration of vitamin C in stomach, large 
intestine and small intestine upon vitamin C withdrawal were 
examined. The concentration of vitamin C in large and small 
intestine was higher than stomach (Fig. 2A-C). In addition, 
it decreased at 1 week after vitamin C withdrawal and it last-
ed for 5 weeks. As we described, vitamin C is a derivative 
of glucose and liver is the site for glycolysis and gluconeo-
genesis (16). Therefore we also examined the concentration In vivo Kinetics of Vitamin C in Gulo
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Figure 2. The changes of vitamin C 
concentration in gastrointestinal or-
gans. The concentration of vitamin 
C of WT and Gulo
−/− mice in (A) 
large intestine, (B) small intestine, 
(C) stomach and (D) liver (n=4∼
10). *p＜0.05, **p＜0.01, ***p
＜0.001 vs. vitamin C-supplemented
Gulo
−/− mice (KO＋VC, 3.3 g/L).
of vitamin C in liver. Relatively low concentration of vitamin 
C was deposited in liver (Fig. 2D). Like a plasma levels of 
vitamin C, the concentration of vitamin C in intestines, stom-
ach and liver of Gulo
−/− mice supplemented with 0.33 g/L 
concentration of vitamin C during the experimental periods 
was examined. It was similar with the concentration in those 
organs of  Gulo
−/− mice that is maintained without vitamin 
C  for  1  week. 
The changes of vitamin C concentration in brain, 
heart and lung
I t i s al re ad y k no w n t h at  vi ta mi n C  pla ys  an  im po rt an t r ol e 
in the collagen synthesis as a co-factor of collagen synthase 
(17). Therefore, it is considered that vitamin C has protective 
effect in brain and heart from the infarction through extensive 
vascular changing. For this reason, we examined the levels 
of  vitamin C  in brain and heart. As  shown in  Fig. 3A and 
B, high concentration of vitamin C was concentrated in both 
brain and heart. Interestingly, we found that the high concen-
t r a t i o n  o f  v i t a m i n  C  w a s  m a i n t a i n e d  i n  b r a i n  u n t i l  t h e  e n d 
of experiments, approximately 1 mM at 5 weeks after vitamin 
C withdrawal. It seems that huge amounts of vitamin C are 
needed to protect brain from the damage by reactive oxygen 
species (ROS), since vitamin C is one of the well-known an-
ti-oxidants. Based on the role of vitamin C as anti-oxidants, 
the concentration in lung was subjected to be analyzed. As 
we  expected,  high  concentration  of  vitamin  C  is  deposited 
as much as brain, but its concentration was more rapidly de-
creased (Fig. 3C). The concentration of vitamin C in brain, 
heart and lung of Gulo
−/− mice supplemented with 0.33 g/L 
concentration of vitamin C was also relatively lower than in 
wild-type or Gulo
−/− mice supplemented with 3.3 g/L of vi-
tamin  C.
The changes of vitamin C concentration in adrenal 
gland, pancreas, testis and kidney
Vitamin  C  is  an  essential  factor  for  the  production  of  hor-
mones (17). So, we investigated the concentration of vitamin 
C  in  some  organs  related  with  the  generation  or  action  of 
hormones.  Adrenal  glands,  which  mainly  produce  cortico-
steroid hormones, contain vitamin C up to 5 mM (Fig. 4A). 
Even though it is also decreased at 1 week after vitamin C 
withdrawal, high concentration of vitamin C was maintained 
till 5 weeks after vitamin C withdrawal. Moreover, relatively In vivo Kinetics of Vitamin C in Gulo
−/− Mice
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Figure 3. The changes of vitamin C concentration in brain, heart and lung. The concentration 
of vitamin C of WT and Gulo
−/− mice in (A) brain, (B) heart, and (C) lung (n=4∼10). **p
＜0.01, ***p＜0.001 vs. vitamin C-supplemented Gulo
−/− mice (KO＋VC, 3.3 g/L).
Figure 4. The changes of vitamin C 
concentration in adrenal gland, 
pancreas, testis and kidney. The 
concentration of vitamin C of WT 
and  Gulo
−/− mice in (A) adrenal 
gland, (B) pancreas, (C) testis and 
(D) kidney (n=4∼10). **p＜0.01, 
***p＜0.001 vs. vitamin C-supple-
mented  Gulo
−/− mice (KO＋VC, 
3.3 g/L).In vivo Kinetics of Vitamin C in Gulo
−/− Mice
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Figure 5. The changes of vitamin C 
concentration in lymph node and 
spleen, and the structural alteration 
in spleen. The concentration of 
vitamin C of WT and Gulo
−/− mice 
in (A) lymph node and (B) spleen 
(n=4∼10). ***p＜0.001 vs. vitamin 
C-supplemented Gulo
−/− mice (KO
＋VC, 3.3 g/L). (C) Splenic tissues 
from WT, Gulo
−/− mice with 
vitamin C (3.3 g/L) supplementation
and  Gulo
−/− mice with vitamin C 
withdrawal for 3∼5 weeks were 
stained with H&E (×100). (D) The 
number of splenocytes and (E) the 
ratio of CD4 to CD8 T cells upon 
vitamin C supplementation and 
withdrawal.
low concentration of vitamin C was detected in pancreas, tes-
tis and kidney (Fig. 4B-D). The sudden fall of vitamin C con-
centration at 1 week after vitamin C withdrawal was also ob-
served in adrenal gland, pancreas, testis and kidney like other 
organs.  The  concentration  of  vitamin  C  in  these  organs  of 
Gulo
−/− mice supplemented with 0.33 g/L of vitamin C was 
similar  to  that  of  Gulo
−/−  mice  with  vitamin  C  withdrawal 
during  the  experimental  periods.
The changes of vitamin C concentration in lymph 
node and spleen
Since the most well-known function of vitamin C is immune 
potentiating, we finally examined the concentration of vitamin 
C in lymph node and spleen. Interestingly, we found that vi-
tamin  C  is  deposited  at  lymph  node  as  much  as  adrenal 
glands  (Fig.  5A).  Even  though  the  level  was  relatively  low 
when it compared with the vitamin C concentration in lymph 
node, spleen contained high concentration of vitamin C like 
h e a r t ,  l a r g e  a n d  s m a l l  i n t e s t i n e s  ( F i g .  5 B ) .  I n  t h e  c a s e  o f  In vivo Kinetics of Vitamin C in Gulo
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spleen, the alteration of splenic architecture in Gulo
−/− mice 
by vitamin C withdrawal for 5 weeks was found (Fig. 5C). 
However, there were no significant differences in the spleno-
cyte numbers and at the ratio between CD4 and CD8 T cell 
(Fig.  5D  and  E).
DISCUSSION
Vitamin C, glutathione, and vitamin E (α-tocopherol) are im-
portant  members  of  intracellular  anti-oxidant  network  and 
they protect organisms from the damages induced by oxygen 
free radicals, such as superoxide anion, nitric oxide and hy-
drogen peroxide. Even though it is known that anti-oxidant 
activity  of  vitamin  C  is  less  than  other  two  molecules,  it 
should be needed for the conversion of oxidized glutathione 
(GSSG) to reduced glutathione (GSH) and tocopheroxyl radi-
cal, an  oxidized  form of  vitamin  E,  to  α-tocopherol  (4,5). 
It means that vitamin C is an essential factor for the main-
tenance of intracellular anti-oxidant network. Based on its an-
ti-oxidant activity, we can suppose that vitamin C is preferen-
tially  accumulated  in  metabolically  active  organs,  such  as 
brain, lung and heart. In fact, it is reported that vitamin C 
uptake is mainly occurred at the endothelium of small intes-
tine and preferentially deposited in brain (4∼10 mM), adre-
nal gland (2∼10 mM), liver (0.8∼1 mM), muscle (0.4 mM) 
and cerebrospinal fluids (CSF; 0.2∼0.4 mM), and 40∼60μM 
of vitamin C is detected in serum and red blood cell (14). 
T o  u n d e r s t a n d  p h y s i o l o g i c a l  m e c h a n i s m s  r e l a t e d  w i t h  t h e  
management  of  organs,  in  vivo v i t a m i n  C  k i n e t i c  s t u d y  r e-
garding accumulation and its consumption in organs is strong-
ly needed. Therefore, we examined in vivo vitamin C kinetic 
study  upon  vitamin  C  withdrawal  by  using  Gulo
−/− m i c e .  
This is the first reports regarding the storage and consumption 
of vitamin C in vivo using animals which cannot synthesize 
vitamin  C  like  human.
  S i n c e  Gulo
−/− mice is unable to synthesize vitamin C in vivo 
like human, 0.33 g/L of vitamin C is recommended for their 
maintenance (www.mmrrc.org). However, we found remark-
able decreasing vitamin C in plasma to the level of scurvy (0.33 
g/L vitamin C-supplemented Gulo
−/− mice: 24.88μM). When 
mice were maintained with 3.3 g/L, it was almost same as WT 
mice (WT: 88.41μM, 3.3 g/L vitamin C-supplemented Gulo
−/− 
mice:  80.90μM).  Most  organ  concentration  of  vitamin  C  in 
Gulo
−/− mice supplemented with 0.33 g/L vitamin C was sim-
ilar to the levels of Gulo
−/− mice with vitamin C withdrawal 
for 1∼2 weeks. It suggests that 0.33 g/L is minimum amounts 
of vitamin C only for the maintenance of Gulo
−/− mice, but 
3.3 g/L is optimal amounts for the investigation of the physio-
logical  functions  of  vitamin  C  in  vivo.  SMP30
−/− m i c e  a r e 
also used as an animal model for the analysis of vitamin C 
functions  in  vivo.  For  the  maintenance  of  SMP30
−/− m i c e ,  
1.5 g/L of vitamin C/day was used, because alternative path-
way for vitamin C synthesis by using of D-glucurono-1, 4-lac-
tone  is  intact  (18).  Therefore,  Gulo
−/−  mice  is  maintained 
with 3.3 g/L concentration of vitamin C supplementation, and 
it is the most suitable experimental model for the assessment 
of  in  vivo v i t a m i n  C  f u n c t i o n s  a n d  i t s  r e l a t e d  m e c h a n i s m s .
    Vitamin C has a crucial role on the hydroxylation of pro-
line, which is closely related to collagen synthesis, blood ves-
sel formation, the synthesis of hormone and neurotransmitter 
and immune functions (19). Therefore, it seems that weight 
loss of Gulo
−/− mice shown in Fig. 1B is caused by the de-
fect of the hydroxylation of proline and collagen synthesis un-
der vitamin C-insufficient condition. In relation with collagen 
s y n t h e s i s ,  t h e r e  a r e  s e v e r a l  r e p o r t s  r e g a r d i n g  t h e  i m p o r t a n t  
role  of  insulin-like  growth  factor  (IGF)  production  (20,21). 
That is to say, severe defect of the synthesis of collagen was 
observed when IGF production is inhibited. Since we have 
previously  reported  that  vitamin  C  inhibits  the  proliferation 
of human melanoma cell lines, SK-Mel2 via the suppression 
o f  I G F  p r o d u c t i o n  ( 2 2 ) ,  t h e  d e f e c t  o f  t h e  h y d r o x y l a t i o n  o f  
proline and collagen synthesis in Gulo
−/− mice under vitamin 
C-insufficient condition should be further investigated. In ad-
dition, the decrease of food intake is regarded as the one of 
the reason for the weight loss of  Gulo
−/− mice. According 
to the report by Odumosu (23), vitamin C supplementation 
reduces weight loss of guinea pigs and its effect is synergisti-
cally up-regulated appetite when administered with serotonin.
    Regarding the roles and functions of vitamin C on the an-
ti-viral  and  anti-tumor  immunity,  it  is  believed  that  vitamin 
C  directly  increased  the  cytotoxic  activity  of  natural  killer 
(NK) cells or antigen specific cytolytic T cells (CTLs), but it 
is still controversial. It is because that most of experiments 
regarding  the  effect  of  anti-viral  and  anti-tumor  immunity 
were  done  in  vitro.  Even  if  the  experiments  were  done  in 
vivo, it was impossible to distinguish whether the anti-viral 
and anti-tumor effects are induced by vitamin C supplementa-
tion, since most animals used in experiments can produce the 
large  amounts  of  vitamin  C  by  themselves.  However,  we 
found that the size of spleen was distinctively reduced and 
the structure of spleen was considerably disrupted in Gulo
−/− 
mice by vitamin C withdrawal for 5 weeks. Therefore, it as-In vivo Kinetics of Vitamin C in Gulo
−/− Mice
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sumes that vitamin C is essential for the maintenance of the 
structure and functions of spleen. We also agree that vitamin 
C can directly increase of anti-viral and anti-tumor activity of 
NK  cell  and  CTLs.  Since  we  have  previously  reported  that 
vitamin  C  directly  induces  apoptosis  of  tumor  via  the 
down-regulation  of  transferrin  receptors  and  mitochondrial 
membrane potential bypassing the activation of NK cells and 
CTLs (24). The maintenance of the highest concentration of 
vitamin  C  via  intravenous  injection  is  useful  for  immunoth-
erapy of cancer patient, since we can expect that vitamin C 
maintains effector functions of immune organs and immune 
cells  as  well  as  directly  induces  apoptosis  of  tumors.
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